×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Tau Kinase Inhibitors
therapeutic
884 words
KG: ent-prot-1e3aff6a
2026-03-23
kind:therapeutic
section:therapeutics
state:published
Contents
Tau Kinase Inhibitors
💊
Therapeutic Info
Name
Tau Kinase Inhibitors
Summary
Page for Tau Kinase Inhibitors
Knowledge Graph
Related Hypotheses (25)
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.45
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.48
Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.48
Cross-Seeding Prevention Strategy
Score: 0.45
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
Pharmacological Enhancement of APOE4 Glycosylation
Score: 0.37
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Proteostasis Enhancement via APOE Chaperone Targeting
Score: 0.50
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Cryptic Exon Silencing Restoration
Score: 0.46
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.44
APOE Isoform Conversion Therapy
Score: 0.44
Glycine-Rich Domain Competitive Inhibition
Score: 0.43
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.42
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding
Score: 0.37
Show 20 more
Related Analyses (6)
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Show 1 more
Related Experiments (5)
Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
Mouse Cdk5, p35, and p39 mutations in neuronal migration
validation · proposed · Score: 0.80
Anti-Tau Immunotherapy Dosing Optimization
clinical · proposed · Score: 0.40
Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo
clinical · proposed · Score: 0.40
Tau Propagation Causality Test — Does Tau Spread Drive Neuro
clinical · proposed · Score: 0.40
See Also (15)
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 4 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 4 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 4 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 4 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 4 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 4 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 4 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 4 hypotheses
Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 4 hypotheses
synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 4 hypotheses
SUMOylation in Neurodegeneration
mechanism · Pages share 4 hypotheses
Show 10 more